Search for a command to run...
Kumail Nanjiani returns to the podcast to discuss his body transformation, stand-up comedy, dealing with online criticism, and his journey of self-acceptance while navigating the complexities of fame, fitness, and personal growth.
Stanford professor Dr. Alia Crum shares groundbreaking research on how changing the "settings" in your mind can transform your body, energy, motivation, and overall health by altering your beliefs and physiological responses.
A deep dive into the booming underground market of Chinese peptides, exploring their growing popularity among tech workers in San Francisco, their unregulated supply chain, and the cultural trends driving their experimental use.
A science-backed exploration of health tips for 2026, covering topics like sleep, nutrition, blood sugar management, arthritis, muscle preservation, and personalized lifestyle experiments.
A comprehensive exploration of why Americans are unhealthy, revealing a unified theory linking caloric abundance, visceral fat, and chronic inflammation to disease, with emerging GLP-1 drugs offering potential therapeutic intervention.
Dr. Martin Picard explores how mitochondria are not just energy producers, but dynamic organelles that transform energy and translate our behaviors, mindset, and experiences into cellular vitality, challenging linear views of aging and offering insights into optimizing health through understanding energy flow.
D.A. Wallach, a former musician turned biotech investor, discusses the unique challenges of investing in biotechnology, including low probabilities of drug success, the potential of AI, and the evolving global landscape of pharmaceutical innovation.
Doximity is a digital workflow platform for healthcare professionals that offers a LinkedIn-like social network, productivity tools, and advertising opportunities, primarily serving pharmaceutical companies looking to reach doctors with targeted marketing.
Dr. Glen Jeffery discusses how long wavelength light can improve mitochondrial function, metabolism, and cellular health, while warning about the potential harmful effects of short wavelength LED lighting on biological systems.
Dr. Joe Dispenza shares his transformative journey of healing from a severe spinal injury through mind-body connection, revealing how individuals can rewire their brain, overcome disease, and create miraculous healing by changing their energy, thoughts, and connection to a quantum field of infinite possibilities.
Eight Sleep's CEO Matteo Franceschetti discusses how his company is using AI and temperature control technology to improve sleep quality, develop a revolutionary sleep product, and potentially transform consumer health.
A deeply personal account of using AI to navigate a son's rapid cancer diagnosis, treatment, and potential future scenarios, revealing AI's transformative potential as a medical advisor and information processor during a critical health crisis.
A comprehensive exploration of thyroid physiology, diagnosis, and treatment, highlighting the complexities of hypothyroidism, the limitations of current diagnostic approaches, and the potential for future research to transform patient care.
Two venture capitalists explore the brutal economics of biotech, revealing why the industry is struggling despite scientific advances, and how new modalities, AI, and a focus on invention could revive innovation in drug development.
Nicholas Berglund shares how Life Time transformed from a traditional gym chain to a luxury wellness country club, focusing on creating meaningful health experiences for members rather than pursuing aggressive sales tactics.
A deep dive into the world of mold-related illness with Ariana Thacker, exploring how mold exposure can cause chronic health issues and the innovative approach of her company Moldco to diagnose and treat these conditions.
Dave Ricks, CEO of Eli Lilly, discusses the company's groundbreaking GLP-1 drugs, their potential beyond weight loss, the complexities of drug development and pricing, and how Eli Lilly is innovating in pharmaceutical research and direct-to-consumer healthcare.
Dr. Jill Bolte Taylor, a Harvard neuroscientist, shares her transformative experience of having a stroke that led her to understand the four distinct characters of the brain and how embracing all parts of our consciousness can lead to a more balanced, compassionate, and fulfilling life.
In this episode, Preston Pysh and Seb Bunney explore David Sinclair's book "Lifespan", discussing the information theory of aging, epigenetics, Yamanaka factors, and the potential for science to slow or reverse the aging process through cellular repair and regeneration.
Celine Halioua discusses her company Loyal's groundbreaking work developing a daily pill for dogs that could extend their lifespan by at least one year, with the first therapy potentially available in 2026 and the potential to pave the way for human longevity research.
In this podcast episode, IQVIA executives discuss how agentic AI is transforming pharmaceutical research and development by streamlining clinical trials, enhancing patient engagement, and accelerating drug development through intelligent automation of complex workflows.
Alex Cohen details his journey from getting fired from multiple companies to founding Hello Patient, a conversational AI startup for healthcare practices that recently raised a $22.5 million Series A. Throughout the episode, he discusses his unconventional path, love for healthcare software, and how his viral Twitter presence has helped him build his company.